Genetically engineered lymphocytes in metastatic melanoma: TIL 1383I TCR transduced T-cells are detectable after infusion. (7th November 2013)

Record Type:: Journal Article
Title:: Genetically engineered lymphocytes in metastatic melanoma: TIL 1383I TCR transduced T-cells are detectable after infusion. (7th November 2013)
Main Title:: Genetically engineered lymphocytes in metastatic melanoma: TIL 1383I TCR transduced T-cells are detectable after infusion
Authors:: Regan, Courtney
Nishimura, Michael
Clark, Ann Lau
Moxley, Kelly
Scurti, Gina
Slepushkin, Vladimir
Roy, Andre
Schonely, Kathy
Dropulic, Boro
Clark, Joseph
Abstract:
Is Part Of:: Journal for immunotherapy of cancer. Volume 1(2013)Supplement 1
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 1(2013)Supplement 1
Issue Display:: Volume 1, Issue 1 (2013)
Year:: 2013
Volume:: 1
Issue:: 1
Issue Sort Value:: 2013-0001-0001-0000
Page Start:
Page End:
Publication Date:: 2013-11-07
Subjects:: Melanoma -- Metastatic Melanoma -- Melanoma Patient -- Fludarabine -- Human Albumin
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105
Journal URLs:: http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗
DOI:: 10.1186/2051-1426-1-S1-P31 ↗
Languages:: English
ISSNs:: 2051-1426
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 19215.xml